阿西替尼-话题@MedSci

#阿西替尼#

21篇内容 | 1266人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1370289, encodeId=6c0913e028988, content=<a href='/topic/show?id=bdec9e943c3' target=_blank style='color:#2F92EE;'>#阿西替尼#</a>, objectTitle=EUR J Cancer：阿西替尼治疗转移性肾细胞癌的真实情景前瞻性研究, objectType=article, longId=125176, objectId=c1181251e66c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1181251e66c, replyNumber=0, likeNumber=52, createdTime=2018-01-01, rootId=0, userName=119337457, userId=fda6311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1181251e66c, moduleTitle=EUR J Cancer：阿西替尼治疗转移性肾细胞癌的真实情景前瞻性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1181251e66c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370288, encodeId=6f0813e0288ac, content=<a href='/topic/show?id=bdec9e943c3' target=_blank style='color:#2F92EE;'>#阿西替尼#</a>, objectTitle=Nature：阿西替尼或可用于治疗耐药性的白血病, objectType=article, longId=47073, objectId=65ae4e07380, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65ae4e07380, replyNumber=0, likeNumber=41, createdTime=2015-02-15, rootId=0, userName=119337457, userId=fda6311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65ae4e07380, moduleTitle=Nature：阿西替尼或可用于治疗耐药性的白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65ae4e07380)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370287, encodeId=0e3813e0287af, content=<a href='/topic/show?id=bdec9e943c3' target=_blank style='color:#2F92EE;'>#阿西替尼#</a>, objectTitle=Lancet Oncol：阿西替尼可作为转移性肾细胞癌患者的二线治疗方案, objectType=article, longId=17730, objectId=efb91e73053, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efb91e73053, replyNumber=0, likeNumber=42, createdTime=2013-04-26, rootId=0, userName=119337457, userId=fda6311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efb91e73053, moduleTitle=Lancet Oncol：阿西替尼可作为转移性肾细胞癌患者的二线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efb91e73053)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阿西替尼

2020-05-29

119337457 (审核中...)

前往app查看评论内容

#阿西替尼#

EUR J Cancer：阿西替尼治疗转移性肾细胞癌的真实情景前瞻性研究

2018-01-01

119337457 (审核中...)

前往app查看评论内容

#阿西替尼#

Nature：阿西替尼或可用于治疗耐药性的白血病

2015-02-15

119337457 (审核中...)

前往app查看评论内容

#阿西替尼#

Lancet Oncol：阿西替尼可作为转移性肾细胞癌患者的二线治疗方案

2013-04-26

科室
- - 订阅+
  - 更多科室
工具
服务